We are live on ! Find out more
OCDX

Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX

Delisted

OCDX was delisted on the 26th of May, 2022.

Back to rankings

140 hedge funds and large institutions have $4.31B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 22 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,167% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 3

223% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 22

143% more call options, than puts

Call options by funds: $2.35M | Put options by funds: $966K

32% more funds holding

Funds holding: 106 → 140 (+34)

13% less capital invested

Capital invested by funds: $4.95B → $4.31B (-$639M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
140
Holders Change
+34
Holders Change %
+32.08%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
38
Increased
71
Reduced
22
Closed
3
Calls
$2.35M
Puts
$966K
Net Calls
+$1.38M
Net Calls Change
-$6.45M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$81.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$63.4M
3
APM
Avidity Partners Management
Texas
+$48.3M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$37.7M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$36.8M

Top Sellers

Rank Fund Capital Flow
1
CG
Carlyle Group
District of Columbia
-$509M
2
Wells Fargo
Wells Fargo
California
-$26.4M
3
DKCM
Davidson Kempner Capital Management
New York
-$15.1M
4
EP
Eversept Partners
New York
-$9.65M
5
Millennium Management
Millennium Management
New York
-$5.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$19M +$3.13M +155,296 +18%
Blackstone Inc
27
Blackstone Inc
New York
$18.5M +$20.1M +1,000,000 New
EP
28
Eversept Partners
New York
$16.9M -$9.65M -479,298 -34%
Charles Schwab
29
Charles Schwab
California
$16.5M +$5.46M +271,220 +44%
Jennison Associates
30
Jennison Associates
New York
$16.3M +$3.04M +151,120 +21%
Norges Bank
31
Norges Bank
Norway
$16.2M +$6.24M +309,760 +55%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$15.1M +$3.28M +163,018 +25%
GCM
33
Ghisallo Capital Management
Massachusetts
$14.4M +$7.05M +350,000 +82%
Point72 Asset Management
34
Point72 Asset Management
Connecticut
$13.9M +$622K +30,912 +4%
RA
35
Royce & Associates
New York
$13M -$3.65M -181,132 -20%
Fiera Capital (Canada)
36
Fiera Capital (Canada)
Quebec, Canada
$12.8M +$3.97M +197,171 +40%
IM
37
Islet Management
New York
$11.2M +$12.2M +603,813 New
BC
38
Brookfield Corp
Ontario, Canada
$10.8M +$7.22M +358,644 +159%
Millennium Management
39
Millennium Management
New York
$10.4M -$5.55M -275,544 -33%
PVI
40
Pura Vida Investments
New York
$10.2M +$11.1M +550,000 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$7.72M +$1.83M +90,921 +28%
Morgan Stanley
42
Morgan Stanley
New York
$6.54M +$1.81M +89,978 +34%
MF
43
Magnetar Financial
Illinois
$6.24M +$6.8M +337,668 New
Goldman Sachs
44
Goldman Sachs
New York
$6.05M +$5.32M +264,162 +419%
VOYA Investment Management
45
VOYA Investment Management
Georgia
$5.98M -$1.41M -69,947 -18%
Prudential Financial
46
Prudential Financial
New Jersey
$5.3M +$3.83M +190,452 +198%
NC
47
Nicholas Company
Wisconsin
$5.27M +$5.74M +285,160 New
FAM
48
Fred Alger Management
New York
$4.62M +$5.03M +250,000 New
SSA
49
Schonfeld Strategic Advisors
New York
$4.55M +$782K +38,841 +19%
Federated Hermes
50
Federated Hermes
Pennsylvania
$4.53M +$2.59M +128,790 +110%
1
2
3 4 5

OCDX Hedge Fund Activity: Q3 2021 in Review

140 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q3 2021, worth a combined $4.31B — down 13% from $4.95B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new OCDX positions and 3 closed out — a net gain of 35 holders — while 71 added to existing stakes and 22 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $81.9M. The largest seller was Carlyle Group, cutting an estimated $509M.

  • 140 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q3 2021, up from 106 in Q2 2021.
  • Funds reported $4.31B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q3 2021, down 13% quarter-over-quarter.
  • 38 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q3 2021 and 3 closed out, a net change of +35 holders.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q3 2021 was T. Rowe Price Associates, an estimated $81.9M added.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q3 2021 was Carlyle Group, an estimated $509M sold.

Based on aggregated 13F filings for Q3 2021.